List of publications

All the publications of the C3M teams.

Export in CSV
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.

Authors Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, Ballotti R

Oncogene May 2012

Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions.

Authors Jacquel A, Obba S, Boyer L, Dufies M, Robert G, Gounon P, Lemichez E, Luciano F, Solary E, Auberger P

Blood May 2012

Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts.

Authors Fenouille N, Grosso S, Yunchao S, Mary D, Pontier-Bres R, Imbert V, Czerucka D, Caroli-Bosc FX, Peyron JF, Lagadec P

The Journal of pathology May 2012

Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis.

Authors Meynet O, Bénéteau M, Jacquin MA, Pradelli LA, Cornille A, Carles M, Ricci JE

Leukemia May 2012

PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials.

Authors Vamecq J, Colet JM, Vanden Eynde JJ, Briand G, Porchet N, Rocchi S

PPAR research May 2012

The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death.

Authors Robert G, Gastaldi C, Puissant A, Hamouda A, Jacquel A, Dufies M, Belhacene N, Colosetti P, Reed JC, Auberger P, Luciano F

Autophagy Apr 2012

Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.

Authors Barr J, Caballería J, Martínez-Arranz I, Domínguez-Díez A, Alonso C, Muntané J, Pérez-Cormenzana M, García-Monzón C, Mayo R, Martín-Duce A, Romero-Gómez M, Lo Iacono O, Tordjman J, Andrade RJ, Pérez-Carreras M, Le Marchand-Brustel Y, Tran A, Fernández-Escalante C, Arévalo E, García-Unzueta M, Clement K, Crespo J, Gual P, Gómez-Fleitas M, Martínez-Chantar ML, Castro A, Lu SC, Vázquez-Chantada M, Mato JM

Journal of proteome research Apr 2012

BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients.

Authors Cluzeau T, Robert G, Mounier N, Karsenti JM, Dufies M, Puissant A, Jacquel A, Renneville A, Preudhomme C, Cassuto JP, Raynaud S, Luciano F, Auberger P

Oncotarget Apr 2012

Prevention of mutagenesis: new potential mechanisms of metformin action in neoplastic cells.

Authors Bost F, Ben-Sahra I, Tanti JF

Cancer prevention research (Philadelphia, Pa.) Apr 2012

[MITF: a genetic key to melanoma and renal cell carcinoma?].

Authors Bertolotto C, Lesueur F, Bressac de Paillerets B

Medecine sciences : M/S Mar 2012